1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,065 | 3,100 | 12:13 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.10. | Riber's first-half 2025 revenue and earnings impacted by deliveries being concentrated into second-half | 1 | Semiconductor Today | ||
| 25.09. | 2025 first-half earnings: RIBER confirms the rollout of its roadmap and its annual outlook | 566 | GlobeNewswire (Europe) | 2025 first-half earnings: RIBER confirms the rollout of its roadmap and its annual outlook. Half-year revenues and earnings, particularly marked by seasonal activity patterns. Order book of €27.7m... ► Artikel lesen | |
| 17.09. | Riber receives Taiwanese order for Compact 21 DZ research MBE system | 2 | Semiconductor Today | ||
| 17.09. | RIBER receives an order in Asia for a research system | 3 | GlobeNewswire (USA) | ||
| 08.09. | New milestone for RIBER in silicon photonics with a ROSIE order in the United States | 1.097 | GlobeNewswire (Europe) | New milestone for RIBER in silicon photonics with a ROSIE order in the United States Bezons (France), 8 September 2025 - 8:00 am - RIBER, a global market leader in molecular beam epitaxy (MBE) equipment... ► Artikel lesen | |
| 18.08. | RIBER receives an order for two production systems in Asia | 1.140 | GlobeNewswire (Europe) | Bezons (France), August 18, 2025 - 8:00 am - RIBER, a global market leader in molecular beam epitaxy (MBE) equipment for the semiconductor industry, announces the order of two new MBE 6000 production... ► Artikel lesen | |
| 23.07. | Riber's first-half revenue falls 22% year-on-year to €10.7m | 11 | Semiconductor Today | ||
| RIBER Aktie jetzt für 0€ handeln | |||||
| 19.06. | Riber partners with Denmark's NQCP, initiating phase II of ROSIE | 1 | Semiconductor Today | ||
| 18.06. | RIBER reaffirms its strategic roadmap at the Annual General Meeting held on June 18, 2025 | 1.018 | GlobeNewswire (Europe) | RIBER reaffirms its strategic roadmap at the Annual General Meeting held on June 18, 2025 Bezons, June 18, 2025 - 5:45 PM - RIBER, a global market leader for molecular beam epitaxy (MBE) equipment... ► Artikel lesen | |
| 17.06. | RIBER completes phase I of ROSIE with a partnership agreement signed with NQCP, a leading research center in Denmark | 934 | GlobeNewswire (Europe) | RIBER completes phase I of ROSIE with a partnership agreement signed with NQCP, a leading research center in Denmark Bezons (France), June 17, 2025 - 6:00pm (CET) - RIBER, the global leader in... ► Artikel lesen | |
| 03.06. | Riber receives order from Asia for MBE 412 research system | 4 | Semiconductor Today | ||
| 03.06. | RIBER receives an order in Asia for an MBE 412 research system | 1 | GlobeNewswire (USA) | ||
| 09.04. | RIBER reports solid growth in sales and earnings in 2024 | 1.413 | GlobeNewswire (Europe) | RIBER reports solid growth in sales and earnings in 2024 Revenues: €41.2m (+5%)Income from ordinary operations: €4.5m, representing 11% of revenues Net income: €4.1m (+21%)Proposed payout of €0.08... ► Artikel lesen | |
| 29.01. | Riber: 2024 business growth in line with guidance | 1.545 | GlobeNewswire (Europe) | 2024 business growth in line with guidance Revenues up +5% to €41.2mOrder book at end-2024: €21.7m Bezons (France), January 29, 2025 - 8:00 am (CET) - RIBER, a global market leader for MBE equipment... ► Artikel lesen | |
| 09.01. | RIBER secures a repeat order for an MBE 412 cluster system in the USA | 3.777 | GlobeNewswire (Europe) | RIBER secures a repeat order for an MBE 412 cluster system in the USA Bezons (France), January 9, 2025 - 8:00am (CET) - RIBER, the global leader for Molecular Beam Epitaxy (MBE) equipment serving... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 23,450 | +3,76 % | EQS-News: Formycon AG: Ranibizumab-Biosimilar Epruvy ab sofort in Deutschland verfügbar | EQS-News: Formycon AG
/ Schlagwort(e): Produkteinführung
Ranibizumab-Biosimilar Epruvy ab sofort in Deutschland verfügbar
20.11.2025 / 06:30 CET/CEST
Für den Inhalt... ► Artikel lesen | |
| GAUZY | 1,985 | 0,00 % | Gauzy Ltd. Announces Second Quarter 2025 Results | Record Backlog Purchase Orders of $42.9 Million at Quarter End Highly Anticipated New Product Lines Announced; Includes Commercial Aircraft Cabin Shading, ADAS Smart Vision for Buses, and Pre-Fabricated... ► Artikel lesen | |
| ONTO INNOVATION | 115,00 | 0,00 % | ONTO INNOVATION INC. - S-8, Securities to be offered to employees in employee benefit plans | ||
| SOLESENCE | 2,130 | -3,62 % | Solésence, Inc.: Solésence Reports Third Quarter 2025 Financial Results | Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN)... ► Artikel lesen | |
| NANOVIRICIDES | 1,080 | +0,93 % | NanoViricides, Inc. Has Filed its Quarterly Report - Subsequent Raise Has Fortified Fiscal Position | SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter... ► Artikel lesen | |
| DOTZ NANO | 0,030 | +5,26 % | XFRA 57N: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| GOMSPACE | 1,254 | -1,26 % | GomSpace Group AB: GomSpace Reports Strong Q3 Performance with continued Growth and Profitability | 94% year-on-year revenue growth and positive EBITDA and EBIT support upgraded full-year guidance, and GomSpace's significantly improved balance sheet strengthens its position to capture current market... ► Artikel lesen | |
| KOPIN | 2,046 | +1,39 % | Kopin Corporation: Michael Murray, Kopin's CEO to Present at THEON International's Capital Markets Day (CMD) on November 6, 2025 | Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical... ► Artikel lesen | |
| FENDX TECHNOLOGIES | 0,300 | -16,67 % | FendX Technologies Inc.: FendX Provides Corporate Update | Vancouver, British Columbia--(Newsfile Corp. - November 21, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company... ► Artikel lesen | |
| ACACIA RESEARCH | 3,060 | +0,66 % | Acacia Research Non-GAAP EPS of -$0.01 beats by $0.13, revenue of $59.4M beats by $21.4M | ||
| NVE | 51,50 | -0,96 % | Dividendenbekanntmachungen (03.11.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADECOAGRO SA LU0584671464 0,1748 USD 0,1515 EUR AMERISERV FINANCIAL INC US03074A1025 0,03 USD 0,026 EUR AON PLC IE00BLP1HW54 0... ► Artikel lesen | |
| ADVANCE ZINCTEK | 0,580 | 0,00 % | ADVANCE ZINCTEK LIMITED: FDA Inspection Update | ||
| LAMPETIA | 0,092 | 0,00 % | EQS-News: Lampetia AG: Halbjahresfinanzbericht auf neuer Webseite | EQS-News: Lampetia AG
/ Schlagwort(e): Halbjahresbericht
LAMPETIA AG: Halbjahresfinanzbericht auf neuer Webseite
30.09.2025 / 19:51 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| NANOFOCUS | 1,800 | 0,00 % | HV-Termine: Hauptversammlungen bei bioXXmed, Borussia Dortmund, CureVac, elexxion, Nanofocus, NSI Asset, OTRS | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| ZENTEK | 0,615 | -2,38 % | Zentek Ltd.: Zentek Receives CRA Notice of Reassessment for 2019 | GUELPH, ONTARIO / ACCESS Newswire / November 21, 2025 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), announces that, further to its press release dated March 21, 2025 regarding the... ► Artikel lesen |
Das Unternehmen RIBER SA kann der Branche Nanotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,005 (-0,17 %) liegt der Kurs bei 3,020 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RIBER SA finden Sie auf Wallstreet Online.